Corinne H. Strawser

SEP 7, 2026 · JOURNAL ARTICLE

Estrogen promotes tumor phenotypes in ER+ and ER– breast cancer through UGDH-GPR30

Jci Insight

This is a mechanistic study using cell lines, animal models, and patient specimens to explore a signaling pathway; it raises questions about UGDH/GPR30 in estrogen-responsive breast cancer but does not report clinical outcomes or hard endpoints that would support practice change.